Lantern Pharma Inc.
LTRN
$4.44
-$0.13-2.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.86% | -7.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.56% | -19.04% | |||
| Operating Income | 2.56% | 19.04% | |||
| Income Before Tax | 4.54% | 22.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.54% | 22.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.54% | 22.78% | |||
| EBIT | 2.56% | 19.04% | |||
| EBITDA | 2.56% | 19.05% | |||
| EPS Basic | 4.54% | 22.09% | |||
| Normalized Basic EPS | 7.62% | 16.35% | |||
| EPS Diluted | 4.54% | 22.09% | |||
| Normalized Diluted EPS | 7.62% | 16.35% | |||
| Average Basic Shares Outstanding | 0.00% | -0.88% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||